Description
Semaglutide is a synthetic GLP-1 (glucagon-like peptide-1) receptor agonist that has gained significant attention in metabolic research. It mimics the activity of endogenous GLP-1, a hormone involved in glucose regulation and appetite control. In preclinical models, Semaglutide has been shown to reduce food intake, promote weight loss, and improve insulin sensitivity, making it a key subject in studies related to obesity, type 2 diabetes, and metabolic syndrome.
Reviews
There are no reviews yet.